In this Expert Interview, Dr. Andrew D. Seidman critically appraises the latest data, addresses the controversies, and opines about adjuvant systemic therapy for breast cancer. Medscape Hematology-Oncology
In men with locally advanced prostate cancer, adding radiation to androgen deprivation therapy cuts in half the risk of dying from the disease. Medscape Medical News
Women in developing nations many not have access to radiation facilities or may delay such treatment. Does radiation still have value in preventing disease recurrence when it is delayed? Medscape Hematology-Oncology
Newly identified genetic variants that are associated with increased susceptibility to prostate cancer have been identified, and this might help pave the way for improvement in diagnosis and treatment. Medscape Medical News
High levels of C-reactive protein (CRP) predict poor outcomes in patients receiving chemoradiotherapy for muscle-invasive bladder cancer, Japanese researchers report in the April issue of BJU International. Reuters Health Information
